Specialized Compounds for High-Risk and Extreme Environments

Publication ID: 24-11857517_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Compounds for High-Risk and Extreme Environments,” Published Technical Disclosure No. 24-11857517_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857517_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,517.

Summary of the Inventive Concept

This inventive concept adapts compounds for treating coronavirus infections to meet the unique demands of high-security, disaster relief, extreme weather, remote, and limited medical infrastructure environments.

Background and Problem Solved

The original patent disclosed compounds for treating coronavirus infections, but it did not address the specific challenges of administering these compounds in high-risk or extreme environments. The new inventive concept solves this problem by introducing specialized variations and niche solutions tailored to these environments.

Detailed Description of the Inventive Concept

The inventive concept encompasses four distinct variations of the original compounds: 1) a system for high-security environments featuring tamper-evident delivery mechanisms, 2) a method for disaster relief operations with rapid deployment and administration capabilities, 3) a composition for extreme weather conditions packaged in weather-resistant containers, and 4) a kit for remote or isolated areas with portable administration devices and storage capabilities for extreme temperatures. These variations ensure the effective treatment of coronavirus infections in environments where standard administration methods are not feasible.

Novelty and Inventive Step

The new inventive concept introduces novel features that differentiate it from the original patent, including secure delivery mechanisms, rapid deployment and administration capabilities, weather-resistant packaging, and portable administration devices. These innovations address specific challenges in high-risk and extreme environments, providing a non-obvious solution to the problem of administering coronavirus treatments in these contexts.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the compound formulation, delivery mechanism, or packaging materials to further adapt to specific environmental challenges. Additionally, the inventive concept could be expanded to address other high-risk or extreme environments not currently addressed.

Potential Commercial Applications and Market

The specialized compounds for high-risk and extreme environments have significant commercial potential in industries such as biodefense, emergency response, and remote healthcare. The market demand for these solutions is driven by the need for effective coronavirus treatments in challenging environments, and the inventive concept is well-positioned to capitalize on this demand.

CPC Classifications

SectionClassGroup
A A61 A61K31/122
A A61 A61K9/0053
A A61 A61K9/0095
A A61 A61K9/127
A A61 A61K9/2009
A A61 A61K9/2013
A A61 A61K9/2018
A A61 A61K9/2054
A A61 A61K9/2095
A A61 A61K9/282
A A61 A61K9/2833
A A61 A61K9/4833
A A61 A61K9/4858
A A61 A61K9/4866
A A61 A61K31/198
A A61 A61K31/222
A A61 A61K31/381
A A61 A61K31/40
A A61 A61K31/422
A A61 A61K31/433
A A61 A61K31/454
A A61 A61K31/513
A A61 A61K31/536
A A61 A61K36/30
A A61 A61P31/14
A A61 A61K2236/51

Field of Art

Pharmaceutical Formulation and Drug Delivery Systems, with specialized expertise in coronavirus treatment compounds, drug packaging, and administration technologies for challenging environments

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or biomedical engineer with advanced degree, expertise in drug formulation, medical device design, and experience developing treatments for infectious diseases, particularly with knowledge of pharmaceutical packaging and delivery mechanisms

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's coronavirus treatment compounds inherently require specialized delivery mechanisms for various environmental conditions. The PTD's variations represent predictable engineering solutions that address known challenges in drug administration, using standard design techniques familiar to pharmaceutical researchers working with sensitive medical compounds.

Obvious Combinations & Variations

Source Patent Element
Coronavirus treatment compound with flexible molecular structure (Formula I)
PTD Variation
Tamper-evident delivery mechanism for high-security environments
Obviousness Reasoning
Standard pharmaceutical engineering practice to develop secure drug delivery systems, particularly for sensitive medical compounds. Predictable application of known medical packaging technologies to protect and control compound administration.
Source Patent Element
Compound with potential for broad therapeutic applications
PTD Variation
Rapid deployment formulation for disaster relief operations
Obviousness Reasoning
Routine pharmaceutical development to create adaptable drug formulations that can be quickly prepared and administered in emergency scenarios. Represents a standard design approach for creating versatile medical treatments.
Source Patent Element
Coronavirus treatment compound with variable molecular substituents
PTD Variation
Weather-resistant packaging for extreme environmental conditions
Obviousness Reasoning
Predictable engineering solution using known materials science techniques to protect pharmaceutical compounds from temperature and humidity variations. Represents a standard approach to developing robust medical packaging.
Source Patent Element
Compound with potential for diverse medical applications
PTD Variation
Portable administration kit for remote or isolated areas
Obviousness Reasoning
Typical pharmaceutical engineering approach to developing self-contained medical delivery systems. Represents a foreseeable solution for expanding treatment accessibility in challenging environments.
Source Patent Element
Coronavirus treatment method with flexible molecular structure
PTD Variation
Remote monitoring platform for areas with limited medical infrastructure
Obviousness Reasoning
Predictable technological extension combining pharmaceutical treatment with telemedicine technologies. Represents a standard approach to solving medical access challenges using existing technological frameworks.
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857517 and the technical variations disclosed herein, a person having ordinary skill in pharmaceutical formulation and drug delivery would find the presented compound adaptations and delivery mechanisms to be obvious extensions of the prior art. The variations represent predictable engineering solutions that would be readily conceived by a skilled practitioner without requiring inventive insight beyond the ordinary capabilities of those working in coronavirus treatment technologies.

Original Patent Information

Patent NumberUS 11,857,517
TitleCompounds for treating corona virus infection
Assignee(s)NLC Pharma Ltd